Company Overview and News

 
Comcast, Charter partner for mobile services back-end software - Channel NewsAsia

2018-04-20 channelnewsasia
Comcast Corp and Charter Communications Inc will partner to develop back-end software to support services for their Xfinity and Spectrum mobile offerings, the companies said on Friday.
Upvote Downvote

 
Comcast, Charter partner for mobile services back-end software

2018-04-20 reuters
(Reuters) - Comcast Corp (CMCSA.O) and Charter Communications Inc (CHTR.O) will partner to develop back-end software to support services for their Xfinity and Spectrum mobile offerings, the companies said on Friday.
Upvote Downvote

 
Hulu's Value Is Now $8.7 Billion, But Still Dwarfed by Netflix - Bloomberg

2018-04-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
5 TV Stocks That Netflix Can’t Beat | InvestorPlace

2018-04-19 investorplace
There seems to be no letup in the powerful momentum with Netflix, Inc. (NASDAQ:NFLX). During the latest earnings report, revenues jumped by 43% and the company added 7.4 million new subscribers. The current membership base is now at 125 million.
Upvote Downvote

 
5 Undervalued Companies In The S&P 500 - April 2018

2018-04-19 seekingalpha
These companies are all rated as suitable for the Defensive Investor and/or the Enterprising Investor following the ModernGraham approach.
Upvote Downvote

 
Deals of the day-Mergers and acquisitions

2018-04-19 reuters
April 19 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: ** Japan’s Takeda Pharmaceutical is in negotiations with Shire after making a third takeover bid worth around $61 billion that was rejected by the London-listed rare diseases drugmaker. ** Brazil’s state-run oil company Petroleo Brasileiro SA is considering selling 60 percent stakes in two regional blocks comprising four refineries, and keeping full ownership of nine other units, it said in a securities filing.
Upvote Downvote

1
10 Fairly Valued Dividend Growth Stocks For Total Return: Part 4

2018-04-19 seekingalpha
One misconception that I come across repeatedly is the idea that if the company’s growth rate increases, then so should its fair value multiple.
Upvote Downvote

 
U.S. first-time unemployment claims dip to 232,000

2018-04-19 feeds.marketwatch
The total value of bonds in the lowest rung of the high-grade universe is bigger than the output of the world’s fifth-largest economy. Its growth is raising alarm bells for some analysts. Full Story
Upvote Downvote

 
NBCU reverses stance to join ‘OpenAP’ TV ad consortium with Viacom, Turner and Fox - MarketWatch

2018-04-19 marketwatch
Comcast Corp.’s NBCUniversal CMCSA, +0.00% has been reluctant to support OpenAP, a TV audience targeting concept from a consortium of TV networks, instead touting its own data and targeting efforts.
Upvote Downvote

 
Sky Posts Strong Sales Ahead of Likely Fox-Comcast Bidding War - Bloomberg

2018-04-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Fox Rejected Higher Comcast Bid Due to Antitrust Concerns - WSJ

2018-04-19 wsj
21st Century Fox Inc. rejected an acquisition offer for its entertainment assets from cable giant Comcast Corp. largely over antitrust concerns, a regulatory filing said, even though the bid was 16% higher on a per-share basis than what Walt Disney Co. ultimately agreed to pay.
Upvote Downvote

 
PRESS DIGEST-New York Times business news - April 19

2018-04-19 reuters
April 19 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.
Upvote Downvote

 
PRESS DIGEST- Wall Street Journal - April 19

2018-04-19 reuters
April 19 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Upvote Downvote

 
Fox chose Disney over Comcast on regulatory, stock fears: filing

2018-04-19 channelnewsasia
Twenty-First Century Fox Inc , which has agreed to sell most of its assets to Walt Disney Co , rejected a deal with another entity that a source identified as Comcast Corp due to higher regulatory risks.
Upvote Downvote

 
10 Fairly Valued Dividend Growth Stocks For Total Return: Part 4

2018-04-18 valuewalkpremium
This is the fourth of a five-part series presenting 50 dividend growth stocks that I have screened for current fair value. With this article, I will be covering 10 additional dividend growth research candidates with moderate to higher yields in addition to the initial 30 that I presented in part 1 found here, part 2 found here and part 3 found here.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 20030N606